by admin | Mar 27, 2024 | News
QuantuMDx are delighted to have been awarded the Outstanding Achievement Award sponsored by Abacus at the 2024 Medilink Healthcare Business Awards. This award was for the Q-POC point of care PCR platform. It was a great evening with some truly inspiring stories....
by QuantuMDx Team | Nov 22, 2022 | Blog, Company Updates, Media Alert
Preventing Antimicrobial Resistance Together Antimicrobial resistance (AMR) describes the situation when microorganisms (bacteria, fungi, parasites and viruses) no longer respond to the drugs (antimicrobials) that are used to treat infections. As a consequence,...
by QuantuMDx Team | Jun 9, 2022 | News
NEWCASTLE UPON TYNE, UK, [9] June 2022. QuantuMDx Group Limited (“QuantuMDx”), a UK-based developer of transformational point-of-care diagnostics, is pleased to announce that it has won the Special Recognition Award (Response to Covid-19)] at the Med-Tech Innovation...
by QuantuMDx Team | May 13, 2022 | News
NEWCASTLE UPON TYNE, UK, [13] May 2022. QuantuMDx Group Limited (“QuantuMDx”), is pleased to announce that it has won the Innovation Award at the Medilink Healthcare Business Awards 2022. The Innovation Award was awarded to the Company’s Q-POC™ platform, recognising...
by QuantuMDx Team | Apr 7, 2022 | News
NEWCASTLE UPON TYNE, UK, 01 APRIL 2022. QuantuMDx Group Limited (“QuantuMDx”), is pleased to announce that it has won two Bionow Awards 2021, which took place last night, Thursday 31 March 2022. The company was shortlisted for three awards, winning two in total. The...
